Check out recent PlatformQ Health News
Developers of rare disease drugs are continually looking for ways to help clinicians reduce the time to correctly diagnose patients and identify those more appropriate for particular therapies. To properly diagnose patients with all types of conditions, clinicians should look beyond what is immediately in front of them and probe...
Immune checkpoint inhibitors have brought tailored treatments for patients with a variety of cancers. This is changing the face of treatment and the practice patterns clinicians have for everything from diagnosis to testing, adverse event management, and survivorship care. To help clinicians prepare for these changes, PlatformQ Health and the...
Advances in disease-modifying therapies for multiple sclerosis can improve the quality of life of patients - yet rapid changes to the treatment landscape left knowledge gaps among providers and patients. In addition, for patients to play a role in their own making, they also need to understand treatment options, side...
Clinicians Love Learning with PlatformQ Health
This activity has allowed me to better do a differential diagnosis between various neuropathies, some of them very similar in symptom presentation.
Clinician learners after participating in Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
After viewing these presentations, I can make use of more tools and alternatives to better explain their disease, and to talk with my patients about other treatment approaches.
Clinician learners after participating in AHA Conference Coverage Heart Failure Virtual Symposium (Clinical Spotlight on Novel Interventions for Patients with Heart Failure)
I am better at adjusting insulin therapy and individualizing the diabetic program for the patient.
Clinician, after participating in Long-acting Insulins In Treatment Of T2dm: Aligning Provider & Patient Perspectives To Address Therapeutic Barriers
I am more competent in prescribing the appropriate drugs. I also know how to involve my patients in health decisions to minimize non adherence.
Clinician, after participating in HIV Update: Adherence Advances with New ART Formulations
Leverage Our Learning Platform
Learn more about the PlatformQ Health Education solution and how to support CME/CE.